| Literature DB >> 35282131 |
.
Abstract
[This corrects the article DOI: 10.21037/atm-20-3647.]. 2022 Annals of Translational Medicine. All rights reserved.Entities:
Year: 2022 PMID: 35282131 PMCID: PMC8848364 DOI: 10.21037/atm-2021-46
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Figure 5H2S-induced autophagy via Sirt1 protects against Ox-LDL-induced apoptosis in HUVECs. HUVECs were pre-treated with or without 3-MA, resveratrol, Ex-527, and GYY4137 for the indicated times followed by treatment with Ox-LDL. (A) Immunoblot analyses showing cleaved-caspase-3 and cleaved-PARP. Expression in control (Ctr) group cells was assigned a value of 1, n≥3. **P<0.01 versus Ctr; #P<0.05 versus Ox-LDL. (B,C) Flow cytometric analysis to detect the apoptosis of HUVECs. n≥3. **P<0.01 versus Ctr; #P<0.05 versus Ox-LDL. (D) Cell viability was measured using the CCK-8 assay. Cell viability in control (Ctr) group was assigned a value of 1, n=6. *P<0.01 versus Ctr; #P<0.05 versus Ox-LDL. Data are expressed as the mean ± SEM. (E) Schematic representation of the effects and mechanisms of H2S on autophagy and apoptosis in HUVECs.